Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2012

Conditions
Allergic Rhinitis
Interventions
DRUG

AZD8848

Nasal spray solution, intranasal, three times weekly for one month

DRUG

Placebo

Nasal spray solution, intranasal, three times weekly for one month

DRUG

AZD8848 and placebo

Nasal spray solution, intranasal, three times weekly for one month

Trial Locations (2)

Unknown

Research Site, Lund

Research Site, Helsingborg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY